$3.02+0.03 (+0.84%)
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally.
American Vanguard Corporation in the Basic Materials sector is trading at $3.02. The stock is currently 49% below its 52-week high of $5.92, remaining 27.9% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 30/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $123.57Mβ | $150.69Mβ | $119.31Mβ | $129.31Mβ | $115.80M |
| Gross Profit | $38.42Mβ | $42.61Mβ | $34.21Mβ | $40.55Mβ | $30.19M |
| Operating Income | $2.63Mβ | $7.95Mβ | $1.81Mβ | $6.27Mβ | -$4.31M |
| Net Income | -$4.14Mβ | -$28.21Mβ | -$12.36Mβ | -$849,000β | -$8.46M |
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthes...
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
Need a quote from a Motley Fool analyst? Douglas Kaye: Thank you, Bobby, and welcome, everyone, to our first quarter 2026 earnings conference call. The year so far for American Vanguard has gotten off to a good start despite continued challenging market conditions, which I will speak to more in a few minutes.
American Vanguard (NYSE:AVD) reported first-quarter fiscal 2026 results showing higher sales and a sharp increase in adjusted EBITDA, as management cited improved domestic demand, better gross margins, and cost controls amid what it described as still-challenging agricultural market conditions. Fir
Companies in The News Are: INTC, CAT, SYY, AVD
The Iran war is dealing a blow to small companies not seen since Covid. The Russell 2000 Index has lost about 218 points so far this month, the most since March 2020, after a two-month winning streak.